NCT00131339View on ClinicalTrials.gov

Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

March 31, 2007

Conditions
Panic Disorder
Interventions
BEHAVIORAL

Cognitive behavioral therapy

DRUG

D-cycloserine

Trial Locations (2)

06106

Hartford Hospital, Hartford

02215

Center for Anxiety and Related Disorders at Boston University, Boston

All Listed Sponsors
lead

Hartford Hospital

OTHER

NCT00131339 - Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder | Biotech Hunter | Biotech Hunter